HELX ETF: Franklin Genomic Advancements ETF - Price, Holdings & Analysis
Franklin Genomic Advancements ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About Franklin Genomic Advancements ETF
What is the current price of HELX?
The latest HELX price is $43.42. The 52-week range is $29.50–$43.40. HELX has returned 47.7% over the past 52 weeks.
What is the expense ratio for HELX?
HELX's annual expense ratio is 0.50%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does HELX pay dividends?
Yes, HELX pays a 0.33% dividend yield. The last ex-dividend date was 2027-01-08. View full dividend history in the Dividends section.
What are the top holdings of HELX?
HELX's largest holdings are Guardant Health, Inc (9.5%), Natera, Inc (7.5%), Krystal Biotech, Inc (5.9%) (combined weight: 23.0%). The fund holds 65 total positions. View the complete portfolio breakdown in the Holdings section.
How does HELX compare to similar ETFs?
Compare HELX (0.50% expense ratio, $29M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.